Abstract
Guanosine, the endogenous guanine nucleoside, prevents cellular death induced by ischemic events and is a promising neuroprotective agent. During an ischemic event, nitric oxide has been reported to either cause or prevent cell death. Our aim was to evaluate the neuroprotective effects of guanosine against oxidative damage in hippocampal slices subjected to an in vitro ischemia model, the oxygen/glucose deprivation (OGD) protocol. We also assessed the participation of nitric oxide synthase (NOS) enzymes activity on the neuroprotection promoted by guanosine. Here, we showed that guanosine prevented the increase in ROS, nitric oxide, and peroxynitrite production induced by OGD. Moreover, guanosine prevented the loss of mitochondrial membrane potential in hippocampal slices subjected to OGD. Guanosine did not present an antioxidant effect per se. The protective effects of guanosine were mimicked by inhibition of neuronal NOS, but not of inducible NOS. The neuroprotective effect of guanosine may involve activation of cellular mechanisms that prevent the increase in nitric oxide production, possibly via neuronal NOS.
Similar content being viewed by others
Abbreviations
- 1400 W:
-
N-(3-(Aminomethyl)benzyl)acetamidine
- 7-NI:
-
7-nitroindazole
- eNOS:
-
Endothelial nitric oxide synthase
- GUO:
-
Guanosine
- HBSS:
-
Hank’s balanced salt solution
- iNOS:
-
Inducible nitric oxide synthase
- KRB:
-
Krebs-Ringer bicarbonate buffer
- L-NAME:
-
L-N G-nitro-L-arginine methyl ester
- MTT:
-
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
- nNOS:
-
Neuronal nitric oxide synthase
- OGD:
-
Oxygen/glucose deprivation
- ONOO− :
-
Peroxynitrite
- ROS:
-
reactive oxygen species
References
Brouns R, De Deyn PP (2009) The complexity of neurobiological processes in acute ischemic stroke. Clin Neurol Neurosurg 111(6):483–95
Donnan GA et al (2008) Stroke. Lancet 371(9624):1612–23
Carden DL, Granger DN (2000) Pathophysiology of ischaemia-reperfusion injury. J Pathol 190(3):255–66
Bolanos JP et al (2009) Mitochondria and reactive oxygen and nitrogen species in neurological disorders and stroke: therapeutic implications. Adv Drug Deliv Rev 61(14):1299–315
Connell BJ et al (2013) Guanosine protects against reperfusion injury in rat brains after ischemic stroke. J Neurosci Res 91(2):262–72
Nanetti L et al (2011) Oxidative stress in ischaemic stroke. Eur J Clin Investig 41(12):1318–22
Moro MA et al (2004) Role of nitric oxide after brain ischaemia. Cell Calcium 36(3–4):265–75
Brown GC (2010) Nitric oxide and neuronal death. Nitric Oxide 23(3):153–65
Bolanos JP, Heales SJ (2010) Persistent mitochondrial damage by nitric oxide and its derivatives: neuropathological implications. Front Neuroenerg 2:1
Kovacs R et al (2009) Endogenous nitric oxide is a key promoting factor for initiation of seizure-like events in hippocampal and entorhinal cortex slices. J Neurosci 29(26):8565–77
Chang R et al (2008) Neuroprotective effects of guanosine on stroke models in vitro and in vivo. Neurosci Lett 431(2):101–5
Lanznaster D et al (2016) Guanosine: a neuromodulator with therapeutic potential in aging-related disorders. Aging Dis 7:5
Uemura Y et al (1991) Neurochemical analysis of focal ischemia in rats. Stroke 22(12):1548–53
Dal-Cim T et al (2011) Guanosine is neuroprotective against oxygen/glucose deprivation in hippocampal slices via large conductance Ca(2) + −activated K+ channels, phosphatidilinositol-3 kinase/protein kinase B pathway activation and glutamate uptake. Neuroscience 183:212–20
Dal-Cim T et al (2016) Neuroprotection promoted by guanosine depends on glutamine synthetase and glutamate transporters activity in hippocampal slices subjected to oxygen/glucose deprivation. Neurotox Res 29(4):460–8
Oliveira IJ et al (2002) Neuroprotective effect of GMP in hippocampal slices submitted to an in vitro model of ischemia. Cell Mol Neurobiol 22(3):335–44
Pocock JM, Nicholls DG (1998) Exocytotic and nonexocytotic modes of glutamate release from cultured cerebellar granule cells during chemical ischaemia. J Neurochem 70(2):806–13
Strasser U, Fischer G (1995) Quantitative measurement of neuronal degeneration in organotypic hippocampal cultures after combined oxygen/glucose deprivation. J Neurosci Methods 57(2):177–86
Trotti D, Danbolt NC, Volterra A (1998) Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration? Trends Pharmacol Sci 19(8):328–34
Liu Y et al (1997) Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J Neurochem 69(2):581–93
Noraberg J, Kristensen BW, Zimmer J (1999) Markers for neuronal degeneration in organotypic slice cultures. Brain Res Brain Res Protoc 3(3):278–90
Pringle AK et al (1996) Selective N-type calcium channel antagonist omega conotoxin MVIIA is neuroprotective against hypoxic neurodegeneration in organotypic hippocampal-slice cultures. Stroke 27(11):2124–30
Ferreira AG et al (2012) Experimental hyperprolinemia induces mild oxidative stress, metabolic changes, and tissue adaptation in rat liver. J Cell Biochem 113(1):174–83
Hernanz R et al (2008) Ouabain treatment increases nitric oxide bioavailability and decreases superoxide anion production in cerebral vessels. J Hypertens 26(10):1944–54
Yang Y et al (2004) Nitric oxide spatial distribution in single cultured hippocampus neurons: investigation by projection of reconstructed 3-D image and visualization technique. Cell Biol Int 28(8–9):577–83
Kooy NW et al (1994) Peroxynitrite-mediated oxidation of dihydrorhodamine 123. Free Radic Biol Med 16(2):149–56
Brandwilliams W, Cuvelier ME, Berset C (1995) Use of a free-radical method to evaluate antioxidant activity. Food Sci Technol Lebensmwiss Technol 28(1):25–30
Colle D et al (2012) Antioxidant properties of Taraxacum officinale leaf extract are involved in the protective effect against hepatoxicity induced by acetaminophen in mice. J Med Food 15(6):549–56
Green LC et al (1982) Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126(1):131–8
Ehrenberg B et al (1988) Membrane potential can be determined in individual cells from the nernstian distribution of cationic dyes. Biophys J 53(5):785–94
Lorrio S et al (2013) Novel multitarget ligand ITH33/IQM9.21 provides neuroprotection in in vitro and in vivo models related to brain ischemia. Neuropharmacology 67:403–11
Perry SW et al (2011) Mitochondrial membrane potential probes and the proton gradient: a practical usage guide. Biotechniques 50(2):98–115
Dal-Cim T et al (2013) Guanosine controls inflammatory pathways to afford neuroprotection of hippocampal slices under oxygen and glucose deprivation conditions. J Neurochem 126(4):437–50
Molz S et al (2011) Neuroprotective effect of guanosine against glutamate-induced cell death in rat hippocampal slices is mediated by the phosphatidylinositol-3 kinase/Akt/glycogen synthase kinase 3beta pathway activation and inducible nitric oxide synthase inhibition. J Neurosci Res 89(9):1400–8
Cardenas A et al (1998) Protective effect of N-(3-(aminomethyl)benzyl) acetamidine, an inducible nitric oxide synthase inhibitor, in brain slices exposed to oxygen-glucose deprivation. Eur J Pharmacol 354(2–3):161–5
Thauerer B, Zur Nedden S, Baier-Bitterlich G (2012) Purine nucleosides: endogenous neuroprotectants in hypoxic brain. J Neurochem 121(3):329–42
Lara DR et al (2001) Effect of orally administered guanosine on seizures and death induced by glutamatergic agents. Brain Res 912(2):176–80
Schmidt AP, Lara DR, Souza DO (2007) Proposal of a guanine-based purinergic system in the mammalian central nervous system. Pharmacol Ther 116(3):401–16
Ribeiro FF et al (2016) Purine nucleosides in neuroregeneration and neuroprotection. Neuropharmacology 104:226–42
Dal-Cim T et al (2012) Guanosine protects human neuroblastoma SH-SY5Y cells against mitochondrial oxidative stress by inducing heme oxigenase-1 via PI3K/Akt/GSK-3beta pathway. Neurochem Int 61(3):397–404
Traversa U et al (2002) Specific [(3)H]-guanosine binding sites in rat brain membranes. Br J Pharmacol 135(4):969–76
Volpini R et al (2011) Evidence for the existence of a specific g protein-coupled receptor activated by guanosine. ChemMedChem 6(6):1074–80
Schmidt AP et al (2008) Guanosine and its modulatory effects on the glutamatergic system. Eur Neuropsychopharmacol 18(8):620–2
Jackson EK et al (2013) Extracellular guanosine regulates extracellular adenosine levels. Am J Physiol Cell Physiol 304(5):C406–21
Hansel G et al (2014) The potential therapeutic effect of guanosine after cortical focal ischemia in rats. PLoS ONE 9(2):e90693
Quincozes-Santos A et al (2014) Guanosine protects C6 astroglial cells against azide-induced oxidative damage: a putative role of heme oxygenase 1. J Neurochem 130(1):61–74
Cossenza M et al (2014) Nitric oxide in the nervous system: biochemical, developmental, and neurobiological aspects. Vitam Horm 96:79–125
Iadecola C (1997) Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 20(3):132–9
Nagafuji T et al (1995) Nitric oxide synthase in cerebral ischemia. Possible contribution of nitric oxide synthase activation in brain microvessels to cerebral ischemic injury. Mol Chem Neuropathol 26(2):107–57
Endres M et al (2004) Targeting eNOS for stroke protection. Trends Neurosci 27(5):283–9
Terpolilli NA, Moskowitz MA, Plesnila N (2012) Nitric oxide: considerations for the treatment of ischemic stroke. J Cereb Blood Flow Metab 32(7):1332–46
Huang Z et al (1994) Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265(5180):1883–5
Vannucchi MG et al (2007) Relationships between neurons expressing neuronal nitric oxide synthase, degree of microglia activation and animal survival. A study in the rat cortex after transient ischemia. Brain Res 1132(1):218–27
Iijima T et al (2003) Mitochondrial membrane potential and intracellular ATP content after transient experimental ischemia in the cultured hippocampal neuron. Neurochem Int 43(3):263–9
Acknowledgments
Research supported by grants from the Brazilian funding agencies to C.I.T.: CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico)–Projects IBN-Net # 01.06.0842-00 and INCT for Excitotoxicity and Neuroprotection; CAPES (Coordenação do Pessoal de Ensino Superior)–Project CAPES-PVE 052/2012; FAPESC (Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina)–Project NENASC. C.I.T. is a recipient of CNPq productivity fellowship and M.P.C. is a recipient of CAPES/PNPD post-doctoral scholarship. The authors state no conflicts of interest. All authors have materially participated in the research and/or article preparation.
Compliance with ethical standards
The procedures used in the present study complied with the guidelines on animal care of the UFSC Ethics Committee on the Use of Animals (CEUA), which follows the “Principles of laboratory animal care” from NIH (2011).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Thomaz, D.T., Dal-Cim, T.A., Martins, W.C. et al. Guanosine prevents nitroxidative stress and recovers mitochondrial membrane potential disruption in hippocampal slices subjected to oxygen/glucose deprivation. Purinergic Signalling 12, 707–718 (2016). https://doi.org/10.1007/s11302-016-9534-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11302-016-9534-3